You are here

shingles

Merck puts 1,000-plus Zostavax lawsuits to bed after plaintiffs file for dismissal

Fierce Pharma

Tue, 07/9/24 - 11:23 am

Dynavax doses first subject in Phase I/II shingles vaccine trial

Clinical Trials Arena

Fri, 06/28/24 - 11:11 am

clinical trials

GSK says efficacy of its shingles vaccine remains high after years

Reuters

Wed, 04/17/24 - 10:06 pm

Curevo’s shingles vaccine equals GSK’s Shingrix in phase 2 head-to-head

Fierce Biotech

Tue, 01/9/24 - 09:47 am

Recibo’s shingles vaccine shows positive safety profile in Phase I trial

Clinical Trials Arena

Tue, 01/2/24 - 09:48 am

clinical trials

GSK signs shingles vaccine deal with China's Zhifei for around $3 bln

Reuters

Mon, 10/9/23 - 10:07 am

Chongqing Zhifei Biological

In GSK's trial of shingles vaccine in China, Shingrix keeps it 100

Fierce Pharma

Wed, 08/23/23 - 10:54 am

Pfizer begins plan to challenge Shingrix with an mRNA vaccine

BioPharma Dive

Sun, 02/12/23 - 07:38 pm

Curevo Vaccine announces closing of $26m Series A1 round

Pharmaceutical Business Review

Thu, 11/17/22 - 10:34 am

GSK’s Shingrix showed to offer ten years of shingles protection in study

Clinical Trials Arena

Thu, 10/20/22 - 10:38 am

clinical trials

The never-ending Zostavax story – in court. Merck gets a win, but thousands more lawsuits pending

Endpoints

Wed, 04/13/22 - 05:15 pm

Moderna to develop mRNA-based shingles vaccine

Yahoo/Reuters

Fri, 02/18/22 - 10:23 am

Moderna Therapeutics

Vaccines upstart Curevo has designs on blockbuster GSK franchise

Pharmaforum

Mon, 02/14/22 - 10:45 am

Pfizer, BioNTech to develop shingles shot, after COVID-19 vaccine success

Reuters

Wed, 01/5/22 - 10:47 am

As GlaxoSmithKline works to get Shingrix back on track, an FDA approval increases the key vaccine's reach

Fierce Pharma

Mon, 07/26/21 - 10:19 pm

GlaxoSmithKline plans to 'relaunch' Shingrix after the pandemic decimated sales

Fierce Pharma

Thu, 06/24/21 - 11:46 pm

FDA adds Guillain-Barré syndrome warning to GlaxoSmithKline’s shingles vaccine

Endpoints

Thu, 03/25/21 - 10:53 pm

Guillain-Barré Syndrome

GSK's Shingrix supply recovers thanks to drop in vaccinations, uninterrupted production

Fierce Pharma

Thu, 07/9/20 - 10:34 pm

JPM: Glaxo sees enormous Shingrix potential, but a supply gap still stands in the way

Fierce Pharma

Thu, 01/16/20 - 12:22 pm

GlaxoSmithKline's Shingrix supply will vault upward, CEO says—in 2024, that is

Fierce Pharma

Fri, 11/15/19 - 10:45 am

Pages